The Bromodomain: A New Target in Emerging Epigenetic Medicine
- PMID: 26596782
- PMCID: PMC7295032
- DOI: 10.1021/acschembio.5b00831
The Bromodomain: A New Target in Emerging Epigenetic Medicine
Abstract
The bromodomain (BrD) is a conserved protein modular domain found in many chromatin- and transcription-associated proteins that has the ability to recognize acetylated lysine residues. This activity allows bromodomains to play a vital role in many acetylation-mediated protein-protein interactions in the cell, ranging from substrate recruitment for histone acetyltransferases (HATs) to aiding in multiple-protein complex assembly for gene transcriptional activation or suppression in chromatin. In recent years, considerable efforts have been made to develop chemical inhibitors of these bromodomains in an effort to probe their cellular functions. Potent and selective inhibitors have been extensively developed for one group of the bromodomain family termed BET proteins that consist of tandem bromodomains followed by an extra terminal domain. Drug developers are actively designing inhibitors of other bromodomains and working to move the most successful inhibitors into the clinic.
Conflict of interest statement
The authors declare no competing financial interest.
Figures


References
-
- Kouzarides T (2007) Chromatin Modifications and Their Function. Cell 128, 693–705. - PubMed
-
- Strahl BD, and Allis CD (2000) The language of covalent histone modifications. Nature 403, 41–45. - PubMed
-
- Thomas MC, and Chiang C-M (2006) The General Transcription Machinery and General Cofactors. Crit. Rev. Biochem. Mol. Biol. 41, 105–178. - PubMed
-
- Berger SL (2007) The complex language of chromatin regulation during transcription. Nature 447, 407–412. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources